Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
10.3389/fimmu.2017.01239 27 DouX.LiS.HuL.DingL.MaY.MaW.et al (2018)
Abnormal EAT acts as a source of pro-inflammatory and fibrotic molecules that can impact adjacent atria, induce atrial myopathy, and generate arrhythmogenic substrates necessary for the initiation and maintenance of AF (101, 102)
no large randomized controlled trials have been published to date, so clinical efficacy and safety remain unestablished [4]
Retatrutide is a triple agonist of the GIP, GLP-1, and glucagon receptors that is currently in development
CRISPR screens in synthetic lethality and combinatorial therapies for cancer
US$ 20.23
US$ 23.54
US$ 24.95
US$ 20.22
US$ 22.54
US$ 23.22
